Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EMD Millipore, the life science division of Merck, has signed a licensing contract with Charles River Laboratories for TrueSpike technology.
Subscribe to our email newsletter
The companies will collaborate to integrate the technology into viral clearance services provided by Charles River, which is designed to result in a consistent study outcome for clients.
TrueSpike technology enables removal of cell debris, DNA, and non-viral proteins from virus preparations used to validate biomanufacturing process virus clearance.
EMD services and solutions vice president Christophe Couturier said the partnership with Charles brings together their regulatory and viral clearance experience and extensive knowledge of virus filtration and process engineering.
Charles River biopharmaceutical services corporate vice president Birgit Girshick said the partnership enhances its ability to exceed client expectations by offering a cost effective, innovative solution.